About: Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary
Creator	Bukta, Evelin Dombrádi, Zsuzsanna Franyó, Dorottya Kocsi, Balázs Szabó, Judit
Source	PMC
abstract	Excessive use of antibiotics contributes to the selection of resistant bacteria and intestinal colonization with multiresistant pathogens poses a risk factor for subsequent infections. The present study assessed vancomycin-resistant enterococci (VRE) carriage rates in patients admitted to our tertiary care hospital. Stool samples sent for routine culturing were screened with vancomycin containing solid or broth enrichment media. VRE isolates were identified with matrix-assisted laser desorption/ionization-time of flight mass spectrometry and antibiotic susceptibilities were tested by E-test. Vancomycin resistance genes were detected by polymerase chain reaction. Medical records of carriers were examined for suspected risk factors for colonization. Altogether 3025 stool specimens were analyzed. Solid media identified a VRE carriage rate of 2.2% while broth enrichment detected 5.8%. Seventy percent of the isolates were Enterococcus faecium. VanB genotype was detected in 38.2%, VanA in 37.3%, VanC1 in 22.6%, and VanC2 in 1.9%. All VRE were sensitive to linezolid, daptomycin, and tigecycline. Collective risk factors for carriage were diabetes, normal flora absence, Clostridioides difficile positivity, longer hospital stay, and advanced age. 78.5% of the carriers received antibiotic therapy which was metronidazole in most cases (47.3%). We recommend regular screening of risk groups such as patients with diabetes, history of recent hospitalization, or former C. difficile infection as an imperative step for preventing VRE dissemination.
has issue date	2019-11-04(xsd:dateTime)
bibo:doi	10.1007/s12223-019-00751-x
bibo:pmid	31686360
has license	cc-by
sha1sum (hex)	d33213a70d81cbea47bc202603ffdba630bac13b
schema:url	https://doi.org/10.1007/s12223-019-00751-x
resource representing a document's title	Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary
has PubMed Central identifier	PMC7244397
has PubMed identifier	31686360
schema:publication	Folia Microbiol (Praha)
resource representing a document's body	covid:d33213a70d81cbea47bc202603ffdba630bac13b#body_text
is schema:about of	named entity 'vancomycin-resistant enterococci' named entity 'polymerase' named entity 'flight' named entity 'risk factor' named entity 'Clostridioides' named entity 'VRE' named entity 'metronidazole' named entity 'sensitive' named entity 'intestinal' named entity 'NORMAL FLORA' named entity 'INTESTINAL' named entity 'CARRIERS' named entity 'EXAMINED FOR' named entity 'MEDIA' named entity 'CONTAINING' named entity 'ANALYZED' named entity 'STEP' named entity 'SUSPECTED' named entity 'REGULAR' named entity 'TIME OF FLIGHT MASS SPECTROMETRY' named entity 'ADVANCED AGE' named entity 'VANC1' named entity 'ANTIBIOTIC THERAPY' named entity 'ASSESSED' named entity 'SELECTION' named entity 'PATHOGENS' named entity 'ROUTINE' named entity 'COLONIZATION' named entity 'SOLID MEDIA' named entity 'Vancomycin' named entity 'linezolid' named entity 'daptomycin' named entity 'colonization' named entity 'pathogens' named entity 'groups' named entity 'broth' named entity 'mass spectrometry' named entity 'preventing' named entity 'received' named entity 'screening' named entity 'pathogens' named entity 'vancomycin-resistant enterococci' named entity 'time of flight mass spectrometry' named entity 'broth' named entity 'risk factor' named entity 'VRE' named entity 'polymerase chain reaction' named entity 'linezolid' named entity 'risk factors' named entity 'C. difficile infection' named entity 'tigecycline' named entity 'resistant bacteria' named entity 'vancomycin' named entity 'poultry' named entity 'Lactobacillus' named entity 'diabetes' named entity 'oral cavity' named entity 'statistically significant' named entity 'decolonization' named entity 'VRE' named entity 'bacterial infection' named entity 'VRE' named entity 'MICs' named entity 'VRE' named entity 'E. faecium' named entity 'E. faecalis' named entity 'blood agar' named entity 'dalfopristin' named entity 'Hungary' named entity 'VRE' named entity 'ventilator' named entity 'nosocomial' named entity 'clinical specimen' named entity '3.2%' named entity 'endemicity' named entity 'European Committee on Antimicrobial Susceptibility Testing' named entity 'teicoplanin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software